Holen Sie sich die Stockscreener-App
33.68
9.39%
-3.49
Vorhandelsmarkt:
33.30
-0.38
-1.13%
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Hims & Hers Health, Inc. (HIMS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Hims & Hers Health Inc (CHIX:82Wd) Stock Price, Trades & News - GuruFocus
Hims & Hers Health (NYSE:HIMS): What Is Driving Attention? - Kalkine Media
This Trade Offers Two Ways To Profit From Hims & Hers Stock - Investor's Business Daily
2026-07-16 | Hims & Hers Health, Inc. (HIMS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NYSE:HIMS | Press Release - Stockhouse
Breakout attempt at $39.02 resistance. Can Hims & Hers Health stock extend gains? - Traders Union
A Look at Hims & Hers Health Inc (HIMS) After 5.8% Gain -- GF Va - GuruFocus
Law firm investigates Hims & Hers for allegedly sharing users' private health data without consent. - Pluang
Lowey Dannenberg, P.C. Investigates Hims & Hers Health, Inc. for Alleged Tracking of User Data - GlobeNewswire
Lowey Dannenberg, P.C. Investigates Hims & Hers Health, Inc. for Alleged Tracking of User Data - GlobeNewswire Inc.
Why is Hims & Hers Health stock up 6.1% today? - Traders Union
Hims & Hers Health shares gain more than 5% after price action confirms trend alignment above key moving averages - Traders Union
Why is Hims & Hers Health stock up today? Resistance test in focus for HIMS - Traders Union
Hims & Hers Health, Inc. (HIMS) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Hims & Hers to announce Q2 2026 results on August 10 - scanx.trade
Is most-watched stock Hims & Hers Health, Inc. (HIMS) worth betting on now? - MSN
Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026 - HIMS Investor Relations
HIMS Stock Logs Worst Week In 2 Months — Turns To Peptides Campaign Ahead Of Key FDA Meeting - Stocktwits
Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now? - Yahoo Finance
Why Is HIMS Stock Slipping Premarket Today? - Stocktwits
Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims - AOL.com
A Look at Hims & Hers Health Inc (HIMS) After 3.0% Decline -- GF Value $39.29 vs Price $34.38 - GuruFocus
Why Hims & Hers Health Shares Are Falling Today - Quiver Quantitative
Hims & Hers Health Stock (HIMS) Opinions on Recent Technical Breakouts and Growth Prospects - Quiver Quantitative
Investor relations - HIMS Investor Relations
HIMS Stock Rises Overnight: CEO Shrugs Off Wild Swings, Bets On ‘Gold Standard’ Of Healthcare Over Next Decade - Stocktwits
HIMS Stock Under Pressure: BofA Warns Wegovy Churn Could Threaten Its Big H2 EBITDA Ramp - Stocktwits
HIMS Stock Hits 2026 High After Unlocking $400M Working Capital Through JPMorgan — Retail Gets Less Bearish - Stocktwits
Hims & Hers Health (HIMS) Draws GLP 1 Attention, Is The Valuation Already Too Rich? - simplywall.st
$Hims & Hers Health (HIMS.US)$ Why Wall Street is watching $HIMS beyond this quarter’s earnings - Moomoo
Truist reiterates Hold on Hims and Hers stock, $23 target on peptide uncertainty - Investing.com
Hims & Hers (HIMS) Stock Jumps 45% — Can This Momentum Continue? - Blockonomi
HIMS Maintains by B of A Securities -- Price Target Raised to $3 - GuruFocus
$Hims & Hers Health (HIMS.US)$ ⸻ $HIMS remains one of the m... - Moomoo
BofA raises Hims and Hers stock price target to $37 on growth - Investing.com Canada
Hims & Hers Health (Ondo Tokenized Stock) Price - Decrypt
Short Seller Who Bet Against Hims & Hers Now Says Its CEO 'Wiped The Floor' With Novo Nordisk - Stocktwits
Hims & Hers Health Options Spot-On: On July 8th, 71,332 Contracts Were Traded, With 958.81K Open Interest - Moomoo
Hims & Hers Health: The Market Still Doesn't Get It - Seeking Alpha
Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners - AOL.com
I Lost 35 Pounds of Postpartum Weight—Here’s How Hers Helped Me Do It - The Healthy @Reader's Digest
Technical Reactions to HIMS Trends in Macro Strategies - Stock Traders Daily
Here's Why Hims & Hers Health, Inc. (HIMS) Fell More Than Broader Market - Yahoo Finance
Hims & Hers CFO Okupe sells $261k in stock - Investing.com
Form 4 Hims Hers Health Inc For: 7 July By Investing.com - Investing.com Nigeria
Hims & Hers CFO Okupe sells $261k in stock By Investing.com - Investing.com Canada
Hims & Hers (NYSE: HIMS) CFO exercises options and sells 7,163 shares under 10b5-1 plan - Stock Titan
HIMS Stock Slips Overnight After FDA Staff Questions Safety Of Popular Peptides — But One Analyst Says ‘This Isn’t The End’ - Stocktwits
Hims & Hers (HIMS) Stock May Be Undervalued After FDA Peptide Questions - Yahoo Finance
Hims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Hims & Hers Health Inc (HIMS) Stock Up 4.0% and Still Undervalued -- GF Score: 81/100 - GuruFocus
Form 144 Hims & Hers Health For: 6 July By Investing.com - Investing.com Canada
[144] Hims & Hers Health, Inc. SEC Filing - Stock Titan
Hims & Hers Health Options Spot-On: On July 6th, 112.7K Contracts Were Traded, With 1.01 Million Open Interest - Moomoo
As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner - MarketBeat
Hims & Hers Health Options Spot-On: On July 2nd, 125.75K Contracts Were Traded, With 987.85K Open Interest - Moomoo
Hims & Hers Health stock falls as insider files to sell shares - Investing.com
HIMS Breakout Signals Structural Business Transformation (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Inc at Morgan Stanley Technology, Media & Telecom Conference Transcript - GuruFocus
Hims & Hers Health Inc Stock Baskets | XSWX:HIMS - GuruFocus
0.08%
1.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):